FadyMalikMDPhD
Cardiology • South San Francisco, CAAdult Congenital Heart Disease, Interventional Cardiology
Cardiology
Dr. Malik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
280 East Grand Ave
South San Francisco, CA 94080Phone+1 650-624-3011Fax+1 650-624-3010
Education & Training
University of California (San Francisco)Fellowship, Cardiovascular Disease, 1996 - 2000- University of California (San Francisco)Residency, Internal Medicine, 1994 - 1996
- University of California San Francisco School of MedicineClass of 1994
Certifications & Licensure
CA State Medical License 1996 - 2024
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 1 citationsCardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.Caroline J Coats, Ahmad Masri, Roberto Barriales-Villa, Theodore P Abraham, Douglas Marshall Brinkley
European Heart Journal. 2024-11-08 - 4 citationsImpact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.Martin S Maron, Ahmad Masri, Michael E Nassif, Roberto Barriales-Villa, Theodore P Abraham
Journal of the American College of Cardiology. 2024-11-05 - 1 citationsStandard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM.Ahmad Masri, Lubna Choudhury, Roberto Barriales-Villa, Perry Elliott, Martin S Maron
Journal of the American College of Cardiology. 2024-11-05
Journal Articles
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, David E Lanfear, Thomas M Suter, Narimon Honarpour, Siddique A Abbasi, Fady I Malik, Christopher E Kurtz, The New England Journal of Medicine
Press Mentions
Cytokinetics Presents Positive Results from Cohort 4 of REDWOOD-HCM and Long-Term Results from FOREST-HCM at the American College of Cardiology 72nd Annual Scientific SessionMarch 4th, 2023- Cytokinetics Presents New Data at the American Heart Association Scientific Sessions 2022November 7th, 2022
- Cytokinetics Presents New Data at the American Heart Association Scientific Sessions 2022November 7th, 2022
- Join now to see all
Grant Support
- Validation Of A Novel Sarcomeric High Throughput AssayNational Heart, Lung, And Blood Institute2001
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
